Clinical Trials in Guangdong, Guangzhou
19 recruiting
Showing 1–18 of 18 trials
Recruiting
Phase 3
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Ph+ ALLLeukemia, Lymphoblastic, Acute, Philadelphia-Positive
Ascentage Pharma Group Inc.350 enrolled90 locationsNCT06051409
Recruiting
Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
NeoplasmsTenosynovial Giant Cell Tumor
Abbisko Therapeutics Co, Ltd276 enrolled17 locationsNCT04192344
Recruiting
Phase 3
A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases
NSCLC Patients With Brain Metastasis
Allist Pharmaceuticals, Inc.380 enrolled1 locationNCT06970639
Recruiting
Phase 2
Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
Advanced NSCLC
Shanghai Junshi Bioscience Co., Ltd.66 enrolled18 locationsNCT06924606
Recruiting
Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound
Contrast Enhanced UltrasoundThyroid Papillary Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University600 enrolled2 locationsNCT07357571
Recruiting
Phase 3
Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)
Breast CancerTriple-Negative Breast Cancer
Fudan University764 enrolled15 locationsNCT05909332
Recruiting
Phase 1
A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low Expression Breast Cancer and Other Solid Tumors
Breast CancerLocally Advanced or Metastatic Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.26 enrolled7 locationsNCT05461768
Recruiting
Phase 1
A Study of HLX42 in Advanced/Metastatic Solid Tumors
Solid Tumor and NSCLC
Shanghai Henlius Biotech102 enrolled1 locationNCT06210815
Recruiting
Not Applicable
Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children
Pediatric CancerHepatoblastoma
Sun Yat-sen University24 enrolled1 locationNCT07188311
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
Solid Tumors
Beijing InnoCare Pharma Tech Co., Ltd.310 enrolled24 locationsNCT04685226
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB - IIIB NSCLC With Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations, Following Complete Surgical Resection With or Without Adjuvant Chemotherapy（FIRMOST）
NSCLCAdjuvant Treatment
Allist Pharmaceuticals, Inc.338 enrolled2 locationsNCT07010419
Recruiting
Phase 2
To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Guangzhou Institute of Respiratory Disease30 enrolled1 locationNCT06341660
Recruiting
Phase 2
A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Guangzhou Institute of Respiratory Disease30 enrolled1 locationNCT06331650
Recruiting
Not Applicable
Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR)
aortic regurgitation
Peijia Medical Technology (Suzhou) Co., Ltd.116 enrolled19 locationsNCT06101888
Recruiting
Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 Inhibitor
Non-small Cell Lung Cancer Stage IIIB/IV
Guangzhou Institute of Respiratory Disease30 enrolled1 locationNCT06310915
Recruiting
Phase 3
Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)
Breast Cancer
Fudan University766 enrolled15 locationsNCT05891093
Recruiting
Phase 3
Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases
RegorafenibColorectal Cancer Liver Metastases
Sun Yat-sen University126 enrolled1 locationNCT05794971
Recruiting
Phase 3
Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases
Brain MetastasesRadiotherapyEGFR Activating Mutation
Sun Yat-sen University232 enrolled1 locationNCT05768490